Boston (1)

Duarte (1)

Portland (1)

Recurrent Chronic Lymphocytic Leukemia (1)

Recurrent Small Lymphocytic Lymphoma (1)

Refractory Chronic Lymphocytic Leukemia (1)

Refractory Small Lymphocytic Lymphoma (1)

Active, not recruiting (1)

phase 2 (1)

City of Hope Medical Center (1)

National Cancer Institute (NCI) (1)

duvelisib (1)

drug (1)

Other (1)

Interventional (1)

Refractory Small Lymphocytic Lymphoma

Showing NaN - NaN of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Active, not recruiting

Oct 7, 2022